Cleveland Biolabs (CBLI) Reports Q1 Loss of $0.06/Share
Get Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
Research and development: 1.1M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Financial Fact:
Research and development: 1.1M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($0.06), versus ($1.14) reported last year. Revenue for the quarter came in at $12.5 thousand, versus $607.3 thousand reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- St. Joe Company (JOE) Reports Q1 EPS of $0.24
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!